Skip to content

Clinical trials

beta-Thalassemia trials in Lebanon

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: beta-Thalassemia Country / region: Lebanon Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20081
20091
20111
20121
20142
20162
20172
20181
20192
20203
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene5
Novartis Pharmaceuticals3
Abfero Pharmaceuticals, Inc1
Boston University1
Forma Therapeutics, Inc.1
HemaQuest Pharmaceuticals Inc.1
Hoffmann-La Roche1
Ionis Pharmaceuticals, Inc.1
La Jolla Pharmaceutical Company1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
beta-Thalassemia19
Thalassemia7
Iron Overload5
Anemia, Sickle Cell2
Hemosiderosis2
alpha-Thalassemia2
Anemia1
Anemia, Hemolytic1
Genetic Diseases, Inborn1
Hematologic Diseases1

Trials

Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.